PFM Health Sciences’s Abcam PLC ABCM Stock Holding History

PFM Health Sciences’s Portfolio ABCM Stock Details ABCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-476,430	Closed	-$11.7M	–	89
2023 Q2	$11.7M	Buy	+476,430	New	+$8.22M	0.45%	55

Other funds holding ABCM

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PFM Health Sciences's ABCM Position: Q3 2023 in Review

PFM Health Sciences sold out of Abcam PLC (ABCM) in Q3 2023, closing a stake of 476,430 shares — an estimated $11.7M sold.

PFM Health Sciences first reported a position in ABCM in Q2 2023 and held it in 1 quarter. The position peaked at $11.7M in Q2 2023. 219 funds tracked by Wall St. Rank hold ABCM as of Q3 2023.

PFM Health Sciences reported no remaining Abcam PLC position as of Q3 2023 after selling out during the quarter.
PFM Health Sciences sold 476,430 Abcam PLC shares in Q3 2023, an estimated $11.7M.
PFM Health Sciences first reported a position in Abcam PLC in Q2 2023 and held it in 1 quarter.
PFM Health Sciences's Abcam PLC position peaked at $11.7M in Q2 2023.
219 funds tracked by Wall St. Rank held Abcam PLC as of Q3 2023.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.